Development code · Small Molecule
PF-06874354
PF-06874354 is a development code for Icalcaprant, developed by Cerevel Therapeutics Holdings, Inc..
- Status
- Phase 2 for Major depressive disorder
- Mechanism
- KOR Antagonist
- Developer
- Cerevel Therapeutics Holdings, Inc.
Programs
- Icalcaprant for Major depressive disorderPhase 2Recruiting
Also known as
- Icalcaprant
- CVL-354
- ABBV-1354
- 2227384-17-8
- 4-[4-[[(2S)-2-(3-methoxy-1-methylpyrazol-4-yl)pyrrolidin-1-yl]methyl]phenoxy]benzamide